CTOR
Citius Oncology, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Citius Oncology (CTOR) Stock: Buy, Sell, or Hold?
$0.57
+0.05 (+9.86%)
▲
5d:
+12.62%
30d:
-23.08%
90d:
-22.46%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (100%)
Quality Score
65/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.54 – $0.78
Position: SLIGHTLY LOW
Forward P/E & Valuation
-3.0x
CHEAP
vs 5.1x historical avg
Wall Street Target
$4.00
+597.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.49 / $0.69
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: CTOR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When CTOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CTOR is currently trading at $0.57, which is considered slightly low relative to its 30-day fair value range of $0.54 to $0.78. From a valuation perspective, the stock is trading at a discount (Forward PE: -3.0) compared to its historical average (5.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CTOR is showing sideways momentum. Immediate support is located at $0.49, while resistance sits at $0.69. The stock is showing strong short-term momentum, up 9.9% recently.
Market Sentiment: CTOR scores 88/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+597.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CTOR is showing sideways momentum. Immediate support is located at $0.49, while resistance sits at $0.69. The stock is showing strong short-term momentum, up 9.9% recently.
Market Sentiment: CTOR scores 88/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+597.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.54 -
$0.78
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
100.0%
Trading Range & Key Levels
30-Day Trading Range
$0.54 -
$0.78
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.49
Resistance Level
$0.69
Current Trend
Sideways
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (88/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.9%)
- BULLISH: Trading 597.1% below Wall St target ($4.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 15% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-3.02
Wall Street Target
$4.00
(+597.1%)
PE vs Historical
-3.0 vs 5.1
CHEAP
Share CTOR Analysis
Share this live CTOR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CTOR)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 7, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment prevails on StockTwits regarding $CTOR with no new information from Yahoo Finance news.
Key Retail Themes:
Delisting
Bearish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 6:09 PM ET
Data refreshes hourly during market hours. Next update: 7:09 PM
Data refreshes hourly during market hours. Next update: 7:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTOR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 30 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 39 SELL |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 47 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 55 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 59 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CTOR Research Pages